Analysis of leading-edge genes within the NR signature identified five consensus differentially expressed NRs in the two discovery cohorts, all expressed at a significantly higher level in LI versus LD tumours—AXIN2, NKD1, APCDD1, NOTUM and DKK4 (figure 2B). The gene discussed is APCDD1; the disease is neoplasm.